DUPIXENT was studied in 2 clinical trials with 724 adults with uncontrolled chronic rhinosinusitis with
nasal polyposis (CRSwNP).
83% fewer patients required
nasal polyp surgery*
Improved the ability to smell in as
little as 2 weeks
Reduced nasal congestion by as
much as 50%†
3 out of 4 patients saw a
reduction in steroid use‡
The most common side effects include injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, high count of a certain white blood cell (eosinophilia), trouble sleeping (insomnia), toothache, gastritis and joint pain (arthralgia).
View the possible side effects of DUPIXENT in patients with uncontrolled chronic rhinosinusitis with nasal polyposis.
*Compared to placebo + standard of care (SOC).
†For patients on DUPIXENT 300 mg in a 24-week and a 52-week clinical trial vs 17% for placebo group.
‡In clinical studies of oral or injected steroid use with DUPIXENT 300 mg + SOC vs placebo + SOC.
Do not change or stop taking your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine to come back.
In clinical studies, utilizing a symptom measurement tool, people taking DUPIXENT saw a meaningful improvement in their nasal polyps symptoms which included—but were not limited to:
The relationship between DUPIXENT and its effect on individual symptoms was studied but not definitively proven. Ask your doctor how DUPIXENT may help.
Our goal is for you to get the most out of the visit to the doctor. Download the Doctor Discussion Guide for tips on how to have a productive conversation, and keep your check-ins effective by using the Symptom Tracker Tool.